Suppr超能文献

年龄和肾功能对头孢尼西药代动力学的影响。

Effect of age and renal function on cefonicid pharmacokinetics.

作者信息

Trang J M, Monson T P, Ackerman B H, Underwood F L, Manning J T, Kearns G L

机构信息

Department of Pharmaceutics, University of Arkansas for Medical Sciences, Little Rock.

出版信息

Antimicrob Agents Chemother. 1989 Feb;33(2):142-6. doi: 10.1128/AAC.33.2.142.

Abstract

Cefonicid (15 mg/kg) was administered intravenously at a constant rate of infusion over 15 min to 10 geriatric patients (mean age, 77 years) and to 4 young subjects (mean age, 35 years). Model-dependent and noncompartmental pharmacokinetic parameters were calculated and found to be congruous; noncompartmental data are reported. Significant differences in the values for area under the curve, mean residence time, total body clearance, and renal clearance were observed between the geriatric and young groups. Mean elimination half-life values were 9.59 and 4.88 h for the geriatric and young groups, respectively. Total body and renal clearances were inversely correlated to age and directly correlated to creatinine clearance. Free fraction was not correlated to albumin concentration but was correlated exponentially to total cefonicid concentration. Despite the prolonged half-life values observed in our geriatric patients, the difference in mean trough concentrations was slight. Daily administration of a 15-mg/kg dose should provide adequate concentrations in serum and should not produce appreciable accumulation in geriatric patients.

摘要

以15分钟的恒定输注速率,向10名老年患者(平均年龄77岁)和4名年轻受试者(平均年龄35岁)静脉注射头孢尼西(15毫克/千克)。计算了基于模型和非房室的药代动力学参数,发现两者一致;报告的是非房室数据。观察到老年组和年轻组在曲线下面积、平均驻留时间、全身清除率和肾清除率的值上存在显著差异。老年组和年轻组的平均消除半衰期值分别为9.59小时和4.88小时。全身清除率和肾清除率与年龄呈负相关,与肌酐清除率呈正相关。游离分数与白蛋白浓度无关,但与头孢尼西总浓度呈指数相关。尽管在我们的老年患者中观察到半衰期值延长,但平均谷浓度的差异很小。每日给予15毫克/千克的剂量应能在血清中提供足够的浓度,且在老年患者中不应产生明显的蓄积。

相似文献

1
Effect of age and renal function on cefonicid pharmacokinetics.
Antimicrob Agents Chemother. 1989 Feb;33(2):142-6. doi: 10.1128/AAC.33.2.142.
2
Multiple-dose pharmacokinetics of cefonicid in patients with impaired renal function.
Antimicrob Agents Chemother. 1986 May;29(5):913-7. doi: 10.1128/AAC.29.5.913.
3
Pharmacokinetics of cefonicid in patients with skin and skin structure infections.
Antimicrob Agents Chemother. 1988 Apr;32(4):485-7. doi: 10.1128/AAC.32.4.485.
4
Cefonicid kinetics in subjects with normal and impaired renal function.
Clin Pharmacol Ther. 1984 Jun;35(6):798-803. doi: 10.1038/clpt.1984.115.
5
Pharmacokinetics of cefonicid in children.
Eur J Clin Pharmacol. 1989;36(1):79-82. doi: 10.1007/BF00561029.
6
Cross-over study of the pharmacokinetics of cefonicid administered intravenously or intramuscularly to healthy adult humans.
Eur J Drug Metab Pharmacokinet. 1985 Jul-Sep;10(3):225-30. doi: 10.1007/BF03189746.
7
Pharmacokinetics of cefonicid in uraemic patients.
J Antimicrob Chemother. 1986 Aug;18(2):203-11. doi: 10.1093/jac/18.2.203.
9
Pharmacokinetic disposition of cefonicid in patients with renal failure and receiving hemodialysis.
Rev Infect Dis. 1984 Nov-Dec;6 Suppl 4:S809-15. doi: 10.1093/clinids/6.supplement_4.s809.
10
Effect of saturable serum protein binding on the pharmacokinetics of unbound cefonicid in humans.
Antimicrob Agents Chemother. 1986 Oct;30(4):565-9. doi: 10.1128/AAC.30.4.565.

引用本文的文献

1
An Overview of the Protein Binding of Cephalosporins in Human Body Fluids: A Systematic Review.
Front Pharmacol. 2022 Jun 28;13:900551. doi: 10.3389/fphar.2022.900551. eCollection 2022.
3
Clinical pharmacokinetics of antibiotics in patients with impaired renal function.
Clin Pharmacokinet. 1992 Mar;22(3):169-210. doi: 10.2165/00003088-199222030-00002.
4
Effects of age and gender on pharmacokinetics of cefepime.
Antimicrob Agents Chemother. 1992 Jun;36(6):1181-5. doi: 10.1128/AAC.36.6.1181.

本文引用的文献

1
Kinetics and renal handling of cefonicid.
Clin Pharmacol Ther. 1981 Nov;30(5):587-93. doi: 10.1038/clpt.1981.208.
2
Pharmacokinetics of cefonicid, a new broad-spectrum cephalosporin.
Antimicrob Agents Chemother. 1982 Jun;21(6):935-8. doi: 10.1128/AAC.21.6.935.
3
Cost comparisons among antimicrobial agents.
N Engl J Med. 1982 Sep 9;307(11):689. doi: 10.1056/NEJM198209093071120.
4
Biological determinants of altered pharmacokinetics in the elderly.
Gerontology. 1982;28 Suppl 1:8-17. doi: 10.1159/000212568.
5
Drug therapy: drug disposition in old age.
N Engl J Med. 1982 May 6;306(18):1081-8. doi: 10.1056/NEJM198205063061804.
6
A microcomputer program in Basic for iterative, non-linear data-fitting to pharmacokinetic functions.
Int J Biomed Comput. 1983 Mar;14(2):95-107. doi: 10.1016/0020-7101(83)90012-0.
7
Cefonicid kinetics in subjects with normal and impaired renal function.
Clin Pharmacol Ther. 1984 Jun;35(6):798-803. doi: 10.1038/clpt.1984.115.
8
Review of cefonicid, a long-acting cephalosporin.
Clin Pharm. 1984 Jan-Feb;3(1):23-32.
10
Effect of saturable serum protein binding on the pharmacokinetics of unbound cefonicid in humans.
Antimicrob Agents Chemother. 1986 Oct;30(4):565-9. doi: 10.1128/AAC.30.4.565.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验